SEARCH

SEARCH BY CITATION

References

  • AYALA, Y.M., CANTWELL, A.M., ROSE, T., BUSH, L.A., AROSIO, D. & DI CERA, E. (2001). Molecular mapping of thrombin-receptor interactions. Proteins: Struct. Funct. Genet., 45, 107116.
  • BAURAND, A., RABOISSON, P., FREUND, M., LEON, C., CAZENAVE, J.P., BOURGUIGNON, J.J. & GACHET, C. (2001). Inhibition of platelet function by administration of MRS2179, a P2Y1 receptor antagonist. Eur. J. Pharmacol., 412, 213221.
  • BERENBAUM, M.C. (1977). Synergy, additivism and antagonism in immunosuppression. A critical review. Clin. Exp. Immunol., 28, 118.
  • BOYER, J.L., ROMERO-AVILA, T., SCHACHTER, J.B. & HARDEN, T.K. (1996). Identification of competitive antagonists of the P2Y1 receptor. Mol. Pharmacol., 50, 13231329.
  • CHOU, T.C. (1998). Drug combinations: from laboratory to practice. J. Lab. Clin. Med., 132, 68.
  • COVIC, L., GRESSER, A.L. & KULIOPULOS, A. (2000). Biphasic kinetics of activation and signaling for PAR1 and PAR4 thrombin receptors in platelets. Biochemistry, 39, 54585467.
  • DANGELMAIER, C., JIN, J., SMITH, J.B. & KUNAPULI, S.P. (2001). Potentiation of thromboxane A2-induced platelet secretion by Gi signaling through the phosphoinositide-3 kinase pathway. Thromb. Haemost., 85, 341348.
  • ECKLY, A., GENDRAULT, J.L., HECHLER, B., CAZENAVE, J.P. & GACHET, C. (2001). Differential involvement of the P2Y(1) and P2Y(T) receptors in the morphological changes of platelet aggregation. Thromb. Haemost., 85, 694701.
  • FOSTER, C.J., PROSSER, D.M., AGANS, J.M., ZHAI, Y., SMITH, M.D., LACHOWICZ, J.E., ZHANG, F.L., GUSTAFSON, E., MONSMA JR, F.J., WIEKOWSKI, M.T., ABBONDANZO, S.J., COOK, D.N., BAYNE, M.L., LIRA, S.A. & CHINTALA, M.S. (2001). Molecular identification and characterization of the platelet ADP receptor targeted by thienopyridine antithrombotic drugs. J. Clin. Invest., 107, 15911598.
  • GUSTAFSSON, D., NYSTROM, J., CARLSSON, S., BREDBERG, U., ERIKSSON, U., GYZANDER, E., ELG, M., ANTONSSON, T., HOFFMANN, K., UNGELL, A., SORENSEN, H., NAGARD, S., ABRAHAMSSON, A. & BYLUND, R. (2001). The direct thrombin inhibitor melagatran and its oral prodrug H 376/95: intestinal absorption properties, biochemical and pharmacodynamic effects. Thromb. Res., 101, 171181.
  • HOLLOPETER, G., JANTZEN, H.M., VINCENT, D., LI, G., ENGLAND, L., RAMAKRISHNAN, V., YANG, R.B., NURDEN, P., NURDEN, A., JULIUS, D. & CONLEY, P.B. (2001). Identification of the platelet ADP receptor targeted by antithrombotic drugs. Nature, 409, 202207.
  • HUMPHRIES, R.G., TOMLINSON, W., INGALL, A.H., CAGE, P.A. & LEFF, P. (1994). FPL 66096: a novel, highly potent and selective antagonist at human platelet P(2T)-purinoceptors. Br. J. Pharmacol., 113, 10571063.
  • HURLEN, M., ABDELNOOR, M., SMITH, P., ERIKSSEN, J. & ARNESEN, H. (2002). Warfarin, aspirin, or both after myocardial infarction. N. Engl. J. Med., 347, 969974.
  • JIN, J., DANIEL, J.L. & KUNAPULI, S.P. (1998). Molecular basis for ADP-induced platelet activation. II. The P2Y1 receptor mediates ADP-induced intracellular calcium mobilization and shape change in platelets. J. Biol. Chem., 273, 20302034.
  • JIN, J. & KUNAPULI, S.P. (1998). Coactivation of two different G protein-coupled receptors is essential for ADP-induced platelet aggregation. Proc. Natl. Acad. Sci. U.S.A., 95, 80708074.
  • KAHN, M.L., NAKANISHI-MATSUI, M., SHAPIRO, M.J., ISHIHARA, H. & COUGHLIN, S.R. (1999). Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin. J. Clin. Invest., 103, 879887.
  • KAUFFENSTEIN, G., BERGMEIER, W., ECKLY, A., OHLMANN, P., LEON, C., CAZENAVE, J.P., NIESWANDT, B. & GACHET, C. (2001). The P2Y(12) receptor induces platelet aggregation through weak activation of the alpha(IIb)beta(3) integrin-a phosphoinositide 3-kinase-dependent mechanism. FEBS Lett., 505, 281290.
  • KIM, S., FOSTER, C., LECCHI, A., QUINTON, T.M., PROSSER, D.M., JIN, J., CATTANEO, M. & KUNAPULI, S.P. (2002). Protease-activated receptors 1 and 4 do not stimulate Gi signaling pathways in the absence of secreted ADP and cause human platelet aggregation independently of Gi signaling. Blood, 99, 36293636.
  • LENAIN, N., FREUND, M., LEON, C., CAZENAVE, J.-P. & GACHET, C. (2003). Inhibition of localized thrombosis in P2Y1-deficient mice and rodents treated with MRS2179, a P2Y1 receptor antagonist. J. Thromb. Haemost., 1, 11441149.
  • LEON, C., HECHLER, B., FREUND, M., ECKLY, A., VIAL, C., OHLMANN, P., DIERICH, A., LEMEUR, M., CAZENAVE, J.P. & GACHET, C. (1999). Defective platelet aggregation and increased resistance to thrombosis in purinergic P2Y(1) receptor-null mice. J. Clin. Invest., 104, 17311737.
  • LORRAIN, J., LECHAIRE, I., GAUFFENY, C., MASSON, R., ROOME, N., O'CONNOR, S., SCHAEFFER, P. & HERBERT, J. (2002). Synergistic anti-thrombotic effect of SanOrg123781A, a synthetic heparin mimetic, in combination with the antiplatelet agent clopidogrel, in a mouse model of electrically-induced carotid artery injury. Blood, abstract 1966.
  • MICHELSON, A.D. (1994). Platelet activation by thrombin can be directly measured in whole blood through the use of the peptide GPRP and flow cytometry: methods and clinical applications. Blood Coag. Fibrinol., 5, 121131.
  • NYLANDER, S. & MATTSSON, C. (2003). Thrombin-induced platelet activation and its inhibition by anticoagulants with different modes of action. Blood Coag. Fibrinol., 14, 159167.
  • NYLANDER, S., MATTSSON, C., RAMSTRÖM, R. & LINDAHL, T.L. (2003). The relative importance of the ADP receptors, P2Y12 and P2Y1 in thrombin-induced platelet activation. Thrombo. Res., 111, 6573.
  • PHILLIPS, D.R., CHARO, I.F., PARISE, L.V. & FITZGERALD, L.A. (1988). The platelet membrane glycoprotein IIb–IIIa complex. Blood, 71, 831843.
  • SHATTIL, S.J., CUNNINGHAM, M. & HOXIE, J.A. (1987). Detection of activated platelets in whole blood using activation-dependent monoclonal antibodies and flow cytometry. Blood, 70, 307315.
  • SHATTIL, S.J., HOXIE, J.A., CUNNINGHAM, M. & BRASS, L.F. (1985). Changes in the platelet membrane glycoprotein IIb IIIa complex during platelet activation. J. Biol. Chem., 260, 1110711114.
  • VAN ES, R.F., JONKER, J.J., VERHEUGT, F.W., DECKERS, J.W. & GROBBEE, D.E. (2002). Aspirin and coumadin after acute coronary syndromes (the ASPECT-2 study): a randomised controlled trial. Lancet, 360, 109113.
  • VU, T.K., HUNG, D.T., WHEATON, V.I. & COUGHLIN, S.R. (1991). Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell, 64, 10571068.
  • YUSUF, S., ZHAO, F., MEHTA, S.R., CHROLAVICIUS, S., TOGNONI, G. & FOX, K.K. (2001). Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N. Engl. J. Med., 345, 494502.
  • ZHANG, F.L., LUO, L., GUSTAFSON, E., LACHOWICZ, J., SMITH, M., QIAO, X.D., LIU, Y.H., CHEN, G.D., PRAMANIK, B., LAZ, T.M., PALMER, K., BAYNE, M. & MONSMA, F.J. (2001). ADP is the cognate ligand for the orphan G protein-coupled receptor SP1999. J. Biol. Chem., 276, 86088615.